Galectin Therapeutics Inc. - Units

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GALTU and buy or sell other stocks, ETFs, and their options commission-free!

About GALTU

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. 

CEO
Joel Lewis, CPA
CEOJoel Lewis, CPA
Employees
Employees
Headquarters
Norcross, Georgia
HeadquartersNorcross, Georgia
Founded
2000
Founded2000
Employees
Employees

GALTU Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.45K
Average volume1.45K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$19.20
52 Week high$19.20
52 Week low
$1.13
52 Week low$1.13

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.